Friday, 31 July 2020

AbbVie announces Positive Phase 3 Data for Atogepant in Migraine Prevention



source https://www.pharmatutor.org/pharma-news/2020/abbvie-announces-positive-phase-3-data-for-atogepant-in-migraine-prevention
at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Pharma openings

  Opportunity for M.Pharm, Msc or PhD as Scientist at PGIMER M.Pharmacy or M.Sc 6 Year of Research Experience or PhD with 3 year of Experien...